BrainScope is a handheld device that uses artificial intelligence and machine learning to identify signs of brain injury in patients.
Through the innovative technology program, Vizient’s clients and providers evaluate medical products based on their ability to innovate healthcare. Vizient innovation technology contracts are awarded after a product review by Vizient member-led councils, according to the Aug. 9 BrainScope press release.
“We are so proud to have received the Innovative Technology contract from Vizient,” CEO of BrainScope Susan Hertzberg said. “Only a select number of companies are awarded this contract designation, and it is further acknowledgement of BrainScope’s potential to become a new standard of care for objectively assessing traumatic brain injuries.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
